share_log

Arcutis Biotherapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Arcutis Biotherapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Arcutis Biotherapeutics | 144:擬議出售證券
美股SEC公告 ·  11/13 00:38

Moomoo AI 已提取核心訊息

Arcutis Biotherapeutics, Inc. Director Terrie Curran is set to sell 8,687 shares of common stock on 11/11/2024, with an aggregate market value of $94,238. The shares to be sold were acquired through restricted stock vests on two separate occasions, with 4,312 shares acquired on 06/01/2023 and an additional 4,375 shares on 05/31/2024. The company has not reported any other securities transactions by Curran in the past three months.
Arcutis Biotherapeutics, Inc. Director Terrie Curran is set to sell 8,687 shares of common stock on 11/11/2024, with an aggregate market value of $94,238. The shares to be sold were acquired through restricted stock vests on two separate occasions, with 4,312 shares acquired on 06/01/2023 and an additional 4,375 shares on 05/31/2024. The company has not reported any other securities transactions by Curran in the past three months.
Arcutis Biotherapeutics, Inc. 董事 Terrie Curran 打算在2024年11月11日賣出8,687股普通股,合計市值爲$94,238。將要出售的股票是通過兩次受限制股票授予獲取的,其中4,312股是在2023年06月01日獲取的,另外4,375股是在2024年05月31日獲取的。公司未報告 Curran 在過去三個月內的任何其他證券交易。
Arcutis Biotherapeutics, Inc. 董事 Terrie Curran 打算在2024年11月11日賣出8,687股普通股,合計市值爲$94,238。將要出售的股票是通過兩次受限制股票授予獲取的,其中4,312股是在2023年06月01日獲取的,另外4,375股是在2024年05月31日獲取的。公司未報告 Curran 在過去三個月內的任何其他證券交易。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息